CN1070408A - 用于治疗骨质疏松症的三氟甲基苄基膦酸酯 - Google Patents

用于治疗骨质疏松症的三氟甲基苄基膦酸酯 Download PDF

Info

Publication number
CN1070408A
CN1070408A CN92109763A CN92109763A CN1070408A CN 1070408 A CN1070408 A CN 1070408A CN 92109763 A CN92109763 A CN 92109763A CN 92109763 A CN92109763 A CN 92109763A CN 1070408 A CN1070408 A CN 1070408A
Authority
CN
China
Prior art keywords
formula
compound
ethyl
group
aralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN92109763A
Other languages
English (en)
Chinese (zh)
Inventor
C·施文德
K·德马雷斯特
D·武斯特罗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of CN1070408A publication Critical patent/CN1070408A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN92109763A 1991-07-18 1992-07-18 用于治疗骨质疏松症的三氟甲基苄基膦酸酯 Withdrawn CN1070408A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US732,267 1991-07-18
US07/732,267 US5300687A (en) 1991-07-18 1991-07-18 Trifluoromethylbenzylphosphonates useful in treating osteoporosis

Publications (1)

Publication Number Publication Date
CN1070408A true CN1070408A (zh) 1993-03-31

Family

ID=24942866

Family Applications (1)

Application Number Title Priority Date Filing Date
CN92109763A Withdrawn CN1070408A (zh) 1991-07-18 1992-07-18 用于治疗骨质疏松症的三氟甲基苄基膦酸酯

Country Status (14)

Country Link
US (2) US5300687A (enExample)
EP (1) EP0524023A1 (enExample)
JP (1) JPH05213977A (enExample)
KR (1) KR930002364A (enExample)
CN (1) CN1070408A (enExample)
AU (1) AU657146B2 (enExample)
CA (1) CA2074020A1 (enExample)
FI (1) FI923289A7 (enExample)
HU (1) HUT62907A (enExample)
IE (1) IE922341A1 (enExample)
MX (1) MX9204229A (enExample)
NO (1) NO922851L (enExample)
TW (1) TW216796B (enExample)
ZA (1) ZA925391B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300687A (en) * 1991-07-18 1994-04-05 Ortho Pharmaceutical Corporation Trifluoromethylbenzylphosphonates useful in treating osteoporosis
ZA941088B (en) * 1993-02-19 1995-09-27 Symphar Sa Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
ATE169924T1 (de) * 1993-05-18 1998-09-15 Takeda Chemical Industries Ltd Benzopyran-derivate und ihre verwendung
AU2808495A (en) * 1994-07-04 1996-01-25 Takeda Chemical Industries Ltd. Phosphonic acid compounds, their production and use
US5691153A (en) * 1996-09-06 1997-11-25 Creighton University Genetic markers to detect high bone mass
US5922697A (en) * 1996-10-02 1999-07-13 Warner-Lambert Company Compounds, compositions and methods for inhibiting the binding of proteins containing an SH2 domain to cognate phosphorylated proteins
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6911553B1 (en) 1997-10-02 2005-06-28 Roche Diagnostics Gmbh Osteoblast-specific mitogens and drugs containing such compounds
EP0906759A1 (de) 1997-10-02 1999-04-07 Roche Diagnostics GmbH Neue Osteoblastenspezifische Mitogene: Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2771102B1 (fr) * 1997-11-14 2000-12-15 Biocoral Inc Procede pour induire la differenciation osteoblastique de cellules de tissu adipeux extramedullaire humain
US6979728B2 (en) * 1998-05-04 2005-12-27 Baylor College Of Medicine Articles of manufacture and methods for array based analysis of biological molecules
US6416737B1 (en) 1998-11-19 2002-07-09 Board Of Trustees Of The University Of Arkansas Increasing bone strength with selected bisphosphonates
US20020150887A1 (en) * 2000-11-09 2002-10-17 National Institute Of Advanced Industrial Science And Technology Methods and nucleic acid probes for molecular genetic analysis of polluted environments and environmental samples
US20050032060A1 (en) * 2001-08-31 2005-02-10 Shishir Shah Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
US7439346B2 (en) * 2001-10-12 2008-10-21 Perkinelmer Las Inc. Nucleic acids arrays and methods of use therefor
EP1451318A4 (en) 2001-10-12 2007-06-27 Perkinelmer Las Inc COMPOSITIONS OF NUCLEIC ACIDS AND ARRAYS AND METHOD FOR THEIR USE
US6916621B2 (en) * 2002-03-27 2005-07-12 Spectral Genomics, Inc. Methods for array-based comparitive binding assays
DE10259245A1 (de) 2002-12-17 2004-07-01 Merck Patent Gmbh Derivate des Asimadolins mit kovalent gebundenen Säuren
JP2006522833A (ja) * 2003-04-11 2006-10-05 バー・ラボラトリーズ，インコーポレイテッド エストロゲンおよびプロゲスチンの投与法
WO2005090370A1 (en) * 2004-02-05 2005-09-29 The Regents Of The University Of California Pharmacologically active agents containing esterified phosphonates and methods for use thereof
WO2006025995A2 (en) * 2004-07-27 2006-03-09 The Regents Of The University Of California Compositions and methods using md-2 mutants and chimeric proteins
CN1302001C (zh) * 2005-01-20 2007-02-28 申厚宝 邻氯苄基膦酸二甲酯生产工艺
US8642577B2 (en) 2005-04-08 2014-02-04 Chimerix, Inc. Compounds, compositions and methods for the treatment of poxvirus infections
US20070003608A1 (en) * 2005-04-08 2007-01-04 Almond Merrick R Compounds, compositions and methods for the treatment of viral infections and other medical disorders
CA2637194A1 (en) 2006-01-18 2007-07-26 National University Corporation Tokyo Medical And Dental University Biomaterial for osteogenesis containing osteogenesis promoter and nanogel
EP2561870A1 (en) 2007-03-30 2013-02-27 Tioga Pharmaceuticals, Inc. Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant and Alternating Irritable Bowel Syndrome
ES2572631T3 (es) * 2008-01-25 2016-06-01 Chimerix, Inc. Métodos de tratamiento de infecciones virales
JP5670329B2 (ja) 2008-07-18 2015-02-18 ジョージア・テック・リサーチ・コーポレーション 有機電子デバイス用の、修飾された仕事関数を有する安定した電極および方法
EP2326707B1 (en) 2008-08-12 2016-11-23 Evolva, Inc. Method for production of isoprenoids
AU2009290563A1 (en) 2008-09-15 2010-03-18 Genentech, Inc. Compositions and methods for regulating cell osmolarity
JP5350733B2 (ja) * 2008-09-30 2013-11-27 株式会社クレハ ホスホン酸、ホスホン酸銅化合物、樹脂組成物及び積層体
KR101745981B1 (ko) 2009-04-06 2017-06-12 조지아 테크 리서치 코포레이션 신규 포스폰산 표면 개질제를 포함하는 전자 소자
US7960456B2 (en) 2009-05-27 2011-06-14 Bromine Compounds Ltd. Halogenated phosphonates, processes for their preparation and their use as flame retardants
US8614200B2 (en) 2009-07-21 2013-12-24 Chimerix, Inc. Compounds, compositions and methods for treating ocular conditions
CA2770282A1 (en) 2009-08-03 2011-02-10 Chimerix, Inc. Composition and methods of treating viral infections and viral induced tumors
PL2534150T3 (pl) 2010-02-12 2017-09-29 Chimerix, Inc. Sposoby leczenia infekcji wirusowej
AU2011248620B2 (en) 2010-04-26 2015-11-26 Chimerix, Inc. Methods of treating retroviral infections and related dosage regimes
EP4174077A1 (en) * 2021-10-27 2023-05-03 Merck Patent GmbH Electronic switching device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2917533A (en) * 1954-05-12 1959-12-15 Virginia Carolina Chem Corp Dialkylaminoalkyl esters of phosphonic acid and method of preparing same
US3363032A (en) * 1964-06-11 1968-01-09 Monsanto Co Long chain aliphatic benzylphosphonic acids, esters and salts
DE3339383A1 (de) * 1983-10-29 1985-05-09 Bayer Ag, 5090 Leverkusen Distyrylverbindungen
US4822780A (en) * 1987-07-08 1989-04-18 Otsuka Pharmaceutical Factory, Inc. Carboxamide compounds
DE4003054A1 (de) * 1990-02-02 1991-08-08 Hoechst Ag Verwendung von benzylphosphonsaeurederivaten zur behandlung von durch viren verursachte krankheiten
US5300687A (en) * 1991-07-18 1994-04-05 Ortho Pharmaceutical Corporation Trifluoromethylbenzylphosphonates useful in treating osteoporosis

Also Published As

Publication number Publication date
HUT62907A (en) 1993-06-28
ZA925391B (en) 1994-01-17
FI923289L (fi) 1993-01-19
IE922341A1 (en) 1993-01-27
CA2074020A1 (en) 1993-01-19
FI923289A7 (fi) 1993-01-19
TW216796B (enExample) 1993-12-01
NO922851D0 (no) 1992-07-17
HU9202353D0 (en) 1992-10-28
NO922851L (no) 1993-01-19
EP0524023A1 (en) 1993-01-20
AU657146B2 (en) 1995-03-02
JPH05213977A (ja) 1993-08-24
MX9204229A (es) 1993-04-01
KR930002364A (ko) 1993-02-23
US5300687A (en) 1994-04-05
US5532226A (en) 1996-07-02
FI923289A0 (fi) 1992-07-17
AU1965692A (en) 1993-01-21

Similar Documents

Publication Publication Date Title
CN1070408A (zh) 用于治疗骨质疏松症的三氟甲基苄基膦酸酯
KR101243039B1 (ko) Ｃ－글리코시드 유도체와 ｌ－프롤린과의 공결정
CN1066713C (zh) 茋衍生物和含有它们的药物组合物
RU2706235C2 (ru) Композиции, пригодные для лечения расстройств, связанных с kit
DE69626684T2 (de) Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
CN1092427A (zh) 具有抗乙型肝炎病毒选择活性的对映体纯β-D-二氧戊环核苷
WO2017219915A1 (zh) 一种腺嘌呤衍生物的膦酸酯前药及其在医药上的应用
CN1078593C (zh) 核苷酸磷酸酯衍生物
CN1202895A (zh) 含咪唑取代基的巯基烷基肽基化合物及其用作基质金属蛋白酶(mmp)和/或肿瘤坏死因子(tnf“抑制剂”
CN1211981A (zh) 氧杂－和硫杂－二唑毒蕈碱受体拮抗剂
JPH03503643A (ja) Ｎ‐複素環プロピリデン‐１，１‐ビスホスホン酸、その製法および薬剤組成物
EP0774257B1 (en) Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration
CN108602786B (zh) 一种取代的噁二唑类化合物及包含该化合物的组合物及其用途
JPH02184694A (ja) フェニル脂肪族アミノアルカンジホスホン酸及びその製造方法並びにそれを含有する医薬
JP2005504777A (ja) オキソアニオン結合に基づく抗菌剤
CN1337956A (zh) 新的吗啉代苯甲酰胺盐
CN1117295A (zh) 作为抗增殖剂的稠合杂环谷氨酸衍生物
JPS6219583A (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩
CN1195344A (zh) 作为nmda受体拮抗剂的多环生物碱衍生物
RU2003129888A (ru) Производные калопорозида, способ их получения и их применение
CN1050845C (zh) 一种Leustroducsin化合物及其在药物制备中的应用及含该化合物的药物组合物
JP4061059B2 (ja) Ｎ−アルコキシアルキル−ｎ−アルキルアミン誘導体またはその塩
CN1673210A (zh) 苯环壬酯光学异构体及其用于制备药物的用途
CN1257478A (zh) 用作抗－心律不齐药物的硝基苯甲酰胺
JPH066578B2 (ja) チアゾリジン誘導体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WW01 Invention patent application withdrawn after publication